|By PR Newswire||
|February 11, 2014 10:39 AM EST||
LINCOLNSHIRE, Ill., Feb. 11, 2014 /PRNewswire/ -- Sysmex America, Inc., a global leader in medical diagnostic testing equipment and information systems technology, today announced that Peter E. Shearstone has been named Vice President of Quality and Regulatory Affairs. Shearstone reports directly to John Kershaw, President and Chief Executive Officer, Sysmex America, Inc. Sysmex America is the U.S. headquarters for Sysmex Corporation, Kobe, Japan and has oversight of the corporation's subsidiaries in Canada and Latin America.
"Peter is a twenty-four year quality professional with exceptional global leadership and medical device industry experience. As an industry veteran, we expect that his national and international expertise in quality management and regulatory affairs will richly support our company's compliance and quality goals. We welcome him to our team," said John Kershaw. Shearstone replaces Peter Osella, who retires in March 2014 after 11 years of service to the company.
Prior to joining Sysmex America, Shearstone served as the Senior Director of Regulatory Communication for Hospira, Inc. Before then, Shearstone was Division Vice President of Global Quality Assurance at Abbott Diagnostics. He also served in senior level positions with Power Medical Interventions and Dade Behring (known now as Siemens Healthcare Diagnostics) as Senior Vice President of Regulatory Affairs and Quality Assurance and Vice President of Global Quality Assurance respectively. Shearstone has spent 22 of his 24 years in the diagnostics industry.
Shearstone earned his bachelor's degree in Biology from Salem State University in Salem, Massachusetts. Shearstone is a member of the American Society for Quality (ASQ), the Regulatory Affairs Professionals Society (RAPS), the International Society of Pharmaceutical Engineers (ISPE) and the Parenteral Drug Association (PDA).
About Sysmex America, Inc.
Sysmex America, Inc., in Lincolnshire, Illinois, the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a trusted world leader in clinical laboratory systemization and solutions that optimize the clinical utility, operational efficiency and financial performance of the lab. Sysmex America distributes and supports a diversified portfolio of best-in-class automated in vitro diagnostic hematology, coagulation and urinalysis analyzers, reagents and information systems for laboratories and healthcare facilities throughout the Western Hemisphere. The Company's unwavering commitment to clinical excellence and technological innovation is reflected in the Sysmex brand and its distinguished heritage of unsurpassed reliability. Sysmex is reshaping the healthcare of tomorrow at the clinical laboratory level by transcending the boundaries of diagnostic science and serving as the pulse of reliable, accountable care. For more information about Sysmex, please visit www.sysmex.com/us
SOURCE Sysmex America, Inc.
Jul. 25, 2016 06:00 PM EDT Reads: 2,070
Jul. 25, 2016 06:00 PM EDT Reads: 1,407
Jul. 25, 2016 06:00 PM EDT Reads: 2,392
Jul. 25, 2016 05:30 PM EDT Reads: 735
Jul. 25, 2016 04:38 PM EDT Reads: 153
Jul. 25, 2016 04:00 PM EDT Reads: 993
Jul. 25, 2016 03:45 PM EDT Reads: 943
Jul. 25, 2016 03:30 PM EDT Reads: 1,684
Jul. 25, 2016 03:15 PM EDT Reads: 415
Jul. 25, 2016 03:00 PM EDT Reads: 1,969
Jul. 25, 2016 02:45 PM EDT Reads: 859
Jul. 25, 2016 02:30 PM EDT Reads: 866
Jul. 25, 2016 02:00 PM EDT Reads: 956
Continuous testing helps bridge the gap between developing quickly and maintaining high quality products. But to implement continuous testing, CTOs must take a strategic approach to building a testing infrastructure and toolset that empowers their team to move fast. Download our guide to laying the groundwork for a scalable continuous testing strategy.
Jul. 25, 2016 01:15 PM EDT Reads: 1,911
Early adopters of IoT viewed it mainly as a different term for machine-to-machine connectivity or M2M. This is understandable since a prerequisite for any IoT solution is the ability to collect and aggregate device data, which is most often presented in a dashboard. The problem is that viewing data in a dashboard requires a human to interpret the results and take manual action, which doesn’t scale to the needs of IoT.
Jul. 25, 2016 01:00 PM EDT Reads: 1,930